Spectrum Planning & Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$220K Buy
2023
Q3
Sell
2023
Q2
$207K Buy
2022
Q4
Sell
2022
Q3
$249K Sell
2022
Q2
$238K Sell
2022
Q1
$310K Hold
2021
Q4
$375K Buy
2021
Q3
$503K Sell
2021
Q2
$740K Sell
2021
Q1
$570K Buy
2020
Q4
$700K Buy